Agilon Stock Today

AGL
 Stock
  

USD 27.07  1.48  5.78%   

Market Performance
17 of 100
Odds Of Distress
Less than 36
Agilon Health is selling for 27.07 as of the 9th of August 2022. This is a 5.78 percent increase since the beginning of the trading day. The stock's lowest day price was 25.78. Agilon Health has about a 36 percent probability of financial distress in the next few years of operation but had a somewhat solid performance during the last 90 days. Equity ratings for Agilon Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 10th of July 2022 and ending today, the 9th of August 2022. Please note, there could be an existing legal relationship between Agilon Health (AGL) and AGL Resources (GAS). Click here to learn more.
Fiscal Year End
December
IPO Date
15th of April 2021
Category
Healthcare
ISIN
US00857U1079
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. The company has 393.66 M outstanding shares of which 19.16 M shares are presently shorted by investors with about 9.85 days to cover. More on Agilon Health

Moving together with Agilon Health

0.71CCMConcord Medical Services Report 21st of October 2022 PairCorr

Moving against Agilon Health

0.88BBIBrickell Biotech Earnings Call  This WeekPairCorr
0.81CGCCanopy Growth Corp Aggressive PushPairCorr
0.75AVAHAveanna Healthcare Earnings Call  TomorrowPairCorr
0.72IONMAssure Holdings Corp Earnings Call  This WeekPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Agilon Health Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Agilon Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Agilon Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Agilon Health appears to be risky and price may revert if volatility continues
The company reported the last year's revenue of 2.07 B. Reported Net Loss for the year was (390.72 M) with profit before taxes, overhead, and interest of 76.41 M.
Agilon Health has about 1.02 B in cash with (130.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.51.
Agilon Health has a frail financial position based on the latest SEC disclosures
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.marketscreener.com: agilon health The Jackson Clinic Adopts Value-Based Care Model to Transform Health Care for Seniors in West Tennessee - Marketscreener.com
New SymbolAGL1
Related EntityGAS (AGL Resources)
CEO, Executive DirectorGianmario Ruos
Thematic IdeaHealthcare (view all)
Fama & French Classification
Average Analyst Recommendation
Analysts covering Agilon Health report their recommendations after researching Agilon Health's financial statements, talking to executives and customers, or listening in on Agilon Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Agilon Health. The Agilon consensus assessment is calculated by taking the average forecast from all of the analysts covering Agilon Health.
Strong Buy9 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Agilon Health based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Agilon Health financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares376 M372.9 M
Slightly Up
Increasing
Slightly volatile
Weighted Average Shares Diluted376 M372.9 M
Slightly Up
Increasing
Slightly volatile
Total Assets1.3 B1.6 B
Significantly Down
Increasing
Slightly volatile
Total Liabilities505.4 M494.7 M
Fairly Up
Increasing
Slightly volatile
Current Assets1.1 B1.4 B
Significantly Down
Increasing
Slightly volatile
Current Liabilities346.8 M357 M
Fairly Down
Increasing
Slightly volatile
Total Debt51.6 M48.4 M
Notably Up
Decreasing
Slightly volatile
Gross Margin0.04460.042
Notably Up
Decreasing
Slightly volatile
Asset Turnover1.581.322
Fairly Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Agilon Health's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Agilon Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Agilon Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Agilon Health's financial leverage. It provides some insight into what part of Agilon Health's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Agilon Health's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Agilon Health deploys its capital and how much of that capital is borrowed.
Liquidity
Agilon Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 55.44 M in debt with debt to equity (D/E) ratio of 0.05, which may show that the company is not taking advantage of profits from borrowing. Agilon Health has a current ratio of 2.62, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Agilon Health until it has trouble settling it off, either with new capital or with free cash flow. So, Agilon Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Agilon Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Agilon to invest in growth at high rates of return. When we think about Agilon Health's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(159.86 Million)
Agilon Health (AGL) is traded on New York Stock Exchange in USA. It is located in 6210 East US Highway 290 and employs 646 people. Agilon Health is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with total capitalization of 10.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Agilon Health's market, we take the total number of its shares issued and multiply it by Agilon Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Agilon Health runs under Healthcare sector within Medical Care Facilities industry. The entity has 393.66 M outstanding shares of which 19.16 M shares are presently shorted by investors with about 9.85 days to cover. Agilon Health has about 1.02 B in cash with (130.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.51.
Check Agilon Health Probability Of Bankruptcy
Ownership
Agilon Health holds a total of three hundred ninety-three million six hundred sixty thousand outstanding shares. The majority of Agilon Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Agilon Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Agilon Health. Please pay attention to any change in the institutional holdings of Agilon Health as this could imply that something significant has changed or about to change at the company. Also note that nearly three million nine hundred thirty-six thousand six hundred invesors are currently shorting Agilon Health expressing very little confidence in its future performance.

Ownership Allocation (%)

Check Agilon Ownership Details

Agilon Stock Price Odds Analysis

What are Agilon Health's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Agilon Health jumping above the current price in 90 days from now is about 6.03%. The Agilon Health probability density function shows the probability of Agilon Health stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.4007. This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Agilon Health will likely underperform. Additionally, the company has an alpha of 0.6632, implying that it can generate a 0.66 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 27.07HorizonTargetOdds Above 27.07
93.93%90 days
 27.07 
6.03%
Based on a normal probability distribution, the odds of Agilon Health to move above the current price in 90 days from now is about 6.03 (This Agilon Health probability density function shows the probability of Agilon Stock to fall within a particular range of prices over 90 days) .

Agilon Health Historical Income Statement

Agilon Health Income Statement is one of the three primary financial statements used for reporting Agilon's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Agilon Health revenue and expense. Agilon Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Agilon Health Weighted Average Shares Diluted is relatively stable at the moment as compared to the past year. The company's current value of Weighted Average Shares Diluted is estimated at 376.03 Million. Income Tax Expense is expected to hike to about 955.9 K this year, although the value of Cost of Revenue will most likely fall to nearly 1.5 B. View More Fundamentals

Agilon Stock Against Markets

Picking the right benchmark for Agilon Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Agilon Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Agilon Health is critical whether you are bullish or bearish towards Agilon Health at a given time.

Similar Equity Warning - AGL

Agilon Health was forked

The entity Agilon Health with a symbol AGL was recently forked. You can potentially use ANGELICA CORP with a symbol AGL1 from now on.

Agilon Health Corporate Directors

Agilon Health corporate directors refer to members of an Agilon Health board of directors. The board of directors generally takes responsibility for the Agilon Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Agilon Health's board members must vote for the resolution. The Agilon Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Paolo Roverato - Non-Executive DirectorProfile
Khadim Hussain - DirectorProfile
Farooq Khan - DirectorProfile
Jacqueline Hey - Non-Executive DirectorProfile

Invested in Agilon Health?

You need to understand the risk of investing before taking a position in Agilon Health. The danger of trading Agilon Health is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Agilon Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Agilon Health. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Agilon Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Agilon Health information on this page should be used as a complementary analysis to other Agilon Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Agilon Stock analysis

When running Agilon Health price analysis, check to measure Agilon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agilon Health is operating at the current time. Most of Agilon Health's value examination focuses on studying past and present price action to predict the probability of Agilon Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Agilon Health's price. Additionally, you may evaluate how the addition of Agilon Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Is Agilon Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilon Health. If investors know Agilon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilon Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
10.4 B
Quarterly Revenue Growth YOY
0.34
Return On Assets
-0.0352
Return On Equity
-0.1
The market value of Agilon Health is measured differently than its book value, which is the value of Agilon that is recorded on the company's balance sheet. Investors also form their own opinion of Agilon Health's value that differs from its market value or its book value, called intrinsic value, which is Agilon Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilon Health's market value can be influenced by many factors that don't directly affect Agilon Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilon Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Agilon Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilon Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.